^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoPlus

    Company:
    University of Chicago
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    The OncoPlus panel is a targeted next generation sequencing (NGS) assay that has the capability to cover 1,213 cancer-related genes for personalized assessments of both solid tumors and hematological malignancies. Variant calling in 147 genes are reportable for clinical patient care.
    Cancer:
    Hematological Malignancies, Solid Tumor
    Gene:
    ALK (Anaplastic lymphoma kinase), Other genes, RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
    Method:
    Next-Generation Sequencing